Pune, India, Dec. 15, 2020 (GLOBE NEWSWIRE) -- The defibrillator market size was valued at USD 9,836.8 Million in 2018. Fortune Business Insights™ states that the market will be valued at USD 14,806.4 Million by 2026, thereby exhibiting a CAGR of 5.3% during the forecast period. North America generated revenue of USD 4,414.1 Million in 2018 and is expected to dominate the market throughout the forecast period. Growing installations of external defibrillators in hospitals, as well as public places such as schools, hotels, streets, railway stations, and others with the aim to prevent fatalities from sudden cardiac arrest, is prominently responsible to hold a higher share of the global defibrillator market in North America.
Defibrillator Industry Developments:
- In April 2019, the government of Australia announced the plan to install an estimated 1,000 defibrillators in parks across the country with aim to offer more safety and availability of emergency services for the people who are suffering from cardiac disorders.
- In June 2018, Koninklijke Philips N.V., announced the acquisition of Remote Diagnostic Technologies, an U.K. based cardiac management and data management company with aim to expand its portfolio in cardiac therapeutic business. Additionaly, Koninklijke Philips N.V is expecting to embed these new technologies in defibrillator in order to offer premium service to the customers.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/defibrillator-market-100950
FDA Approves Wearable Defibrillator for Children
The FDA approved ‘LifeVest’ defibrillator has been successful ever since it was announced in 2017. The LifeVest was launched as a wearable device, suitable for children at the risk of sudden cardiac arrest. The device consists of an electrode belt and a cloth that surrounds the chest of the patient using it.
Additionally, the device also makes use of a monitor that is used for real time analysis. The efficacy of the device has lifted the otherwise moderately rising defibrillator market. The device provides a shock to the heart, whenever a failure is detected, allowing it to restore its heartbeat. LifeVest has a positive outcome on the global defibrillators market and is likely to enable growth of the market in the coming years.
To get to know more about the short-term & long-term impact of COVID-19 on this market, please click here: https://www.fortunebusinessinsights.com/industry-reports/defibrillator-market-100950
Boston Scientific Proposes a Defibrillator with 70% More Pacing Options
Boston Scientific receives FDA approval for its newest range of defibrillators, designed to better patient care. The company received approvals for Dynagen Mini and Inogen Mini, along with Dynagen X4 and Inogen X4. The company claims that the X4 lines of defibrillators offer 70% more pacing options for gathering elevated threshold levels.
The size of these devices are what differentiates them from its counterparts and it has created a rising uptake within end users. The company has submitted on its website that these devices are approximately 20% smaller than the existing devices, produced by its counterparts. The approvals for Boston Scientific’s latest devices is likely to enable the growth of the global market in the forthcoming years.
Quick Buy - Defibrillator Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100950
List of the leading companies that are operating in the global defibrillator market:
- Asahi Kasei Corporation
- Philips Healthcare
- Defibtech, LLC.
- Cardiac Science
- Stryker
- CU Medical System Inc.
- Medtronic
- Boston Scientific Corporation
- Biotronik
- LivaNova Plc
- Abbott
- Microport
- Other prominent players
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/defibrillator-market-100950
Global Defibrillator Market Segmentation:
By Type
• Implantable Cardioverter Defibrillator (ICD)
• Transvenous ICD
• Single Chamber ICD
• Dual Chamber ICD
• CRT-D (cardiac resynchronization therapy- defibrillator)
• Subcutaneous ICD
• External Defibrillator
• Automated External Defibrillator (AED)
• Manual and Semi-Automatic External Defibrillator
• Wearable External Defibrillator
By End User
• Hospitals & Clinics
• Ambulatory, Schools and other Public Places
By Geography
• North America (USA and Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
• Rest of the World
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/defibrillator-market-100950
SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:
- Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
- Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
- Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
- Number of procedures and average price of procedures
- Replacement rate and pricing of capital equipment
- Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
- Market & technological trends, new product developments, product pipeline.
Have a Look at Related Reports:
In-vitro Diagnostics (IVD) Market Share & Industry Analysis, By Product Type (Instruments, Reagents & Consumables), By Technique (Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Point of Care, Hematology and Others), By Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology, Others), By End User (Clinical Laboratories, Hospitals, Physicians Offices, Others) and Regional Forecast, 2019 – 2026
Hepatitis C Drug Market Share & Industry Analysis, By Product (NS5A Inhibitor (Protease Inhibitors), Fixed-dose Combination, Others), By Disease Type (Acute Hepatitis C, Chronic Hepatitis C), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026
Schizophrenia Drugs Market Share & Industry Analysis, By Therapeutic Class (Second Generation, Third Generation, Others), By Treatment (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) and Regional Forecast, 2019-2026
Sharps Containers Market Share & Industry Analysis, By Product Type (Multipurpose Containers, Patient Room Containers, Phlebotomy Containers), By Waste Generators (Hospitals, Pharmacies, Academic & Research Institutes, Others), By Usage (Reusable Containers and Single-Use Containers), By Waste Type (Sharps Waste, Infectious Waste), By Size (1–2 Gallons, 2–4 Gallons, 4–8 Gallons Others) and Regional Forecast, 2019 - 2026
Aesthetic Implants Market Share & Industry Analysis, By Product (Breast Implants, Dental Implants, Facial Implants & Others), By Gender (Female, Male), By End-user (Hospitals, Specialty Clinics), and Regional Forecast, 2019-2026
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/defibrillator-market-9176